William W. Storms, M.D.

 

Publications

Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years. W Storms, TM Michele, B Knorr, et al.  Clin Exp Allergy, 2001;31(1):77-87.

 

Patient preference of inhaled nasal corticosteroids. W. Storms, Allergy and Asthma Proc Vol 22, No 6:S1-3, S27-28, Nov – Dec 2001.

 

New Rules for Olympic Athletes who take B2 Agonists: The IOC is Watching. J Weiler, W Storms, Amer Journal of Medicine & Sports, Vol IV, No II, March/April 2002.

 

Rethinking our approach to allergic rhinitis management. WW Storms, Ann Allergy Asthma Immunol, 2002;88(Suppl):30-35, April 2002.

 

Allergens in the pathogenesis of asthma potential role of anti-immunoglobulin E therapy. W Storms, Am J Respir Med 2002; 1 (5):361-368.

 

Review of exercise-induced asthma. W Storms, Med Sci Sports Exerc, Vol. 35, No. 9;1464-1470, 2003.

 

Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes. W Storms, Ann Allergy Asthma Immunol, 2003;91:131-40, August 2003.

 

Unmet needs in the treatment of allergic asthma: potential role of novel biologic therapies. W Storms, J Managed Care Pharm, 2003;9 (6):534-43, November/December 2003.

 

Clinical trials: Are these your patients? W Storms, J Allergy Clin Immunol 2003;112:S107-11.

 

Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. W Storms, J Allergy Clin Immunol 2004;114 (Suppl):S146-53, November 2004.

 

A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.  W Storms, P Chervinsky, AF Ghannam, et al., Respir Med 2004;98(11):1051-62, November 2004.

 

Cromolyn sodium: fitting an old friend into current asthma treatment. W Storms, MA Kaliner, J Asthma 2005;42(2):79-89, March 2005.

 

Asthma therapy: changing perspectives. W Storms, J Resp Dis 2005;26(10):S5-7, October 2005.

 

The use of anti-IgE strategies in asthma management: Applying emergent learning to the clinical practice setting, A CME Monograph.  A Liu, W Storms, Oceanside Publications, February 2006.

 

Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone. A Weaver, RP Messner, W Storms, et al., J Clin Rheumatol, 2006;12:17-25.

 

Therapeutic options for reducing sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis. W Storms, B Yawn, L Fromer, Cur Med Res Opin., 2007;23(9):2135-2146.

 

Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction.  W Storms, Expert Opin. Pharmacother., 2007;8(13):1-14.

 

A comparison of the effects of oral montelukast and inhaled Salmeterol on response to rescue bronchodilation after challenge.  W Storms, P Chervinsky, AF Ghannam, et al, Respir Med, 2004;98(11):1051-62.

 

Challenges in the management of Exercise-induced asthma.  W. Storms, Expert Rev. Clin Immunol 2009; 5(3): 261-269.

 

Exercise-Induced Bronchospasm, Storms WW. Curr Sports Med Rep, Vol 8, No 2, pp 45-46, March/April 2009.

 

Guaifenesin in Rhinitis, Storms WW, Farrar JR, Current Allergy and Asthma Reports, 9(2):101-106, March 2009.

 

BOOK CHAPTERS

Storms WW, “Do asthma medications enhance sports performance in athletes who do not have asthma?”, in Allergic and Respiratory Diseases in Sports Medicine, edited by John M. Weiler, Vol. II, 389-398, Marcel Dekker, New York, 1997.

 

Storms WW, “Allergies and Sports, in Asthma and Exercise”, in Human Kinetics, edited by Rundell, Wilber and Lemanske, 2002.

 

Storms WW, “Allergy Diagnostic Procedures”, in Practical Allergy, edited by Milgrom, Usatine, and Spector, Mosby, 2001.

 

Storms WW, “Allergic Rhinitis Caused by Inhalant Factors”, in Conn’s Current Therapy, edited by Rakel and Bope, 2003.

 

Storms WW, “Role of allergies in the provocation of exercise-induced asthma”, in Exercise-induced Asthma; Pathophysiology and Treatment, edited by Rundell, Wilbur and Lemanske, 2002.

 

Storms WW, Milgrom EC, “Skin Testing”, in Practical Allergy, edited by Milgrom, Usatine, Tan and Spector, 2004.

 

Storms WW, Milgrom EC, “Radioallergosorbent Testing (RAST)”, in Practical Allergy, edited by Milgrom, Usatine, Tan and Spector, 2004.

 

Storms WW, “Asthma Associated With Exercise”, in Immunol Allergy Clin North Am 2005;25(1):31-43.

 

Storms WW, Drazen JM, “Role of Leukotriene Antagonists in the Treatment and Prevention of Acute Asthma Exacerbations”, in Exacerbations of Asthma, edited by Johnston and O’Byrne, 2006.

 

Storms WW, Bonini S, Carlsen KH, “Sports and Allergies”, in WAO-White Book on Allergy, March 2011, Sec 2.10.

 

 

Matthew S. Bowdish, M.D.

 

Publications

Fan J, Nishanian P, Breen EC, McDonald M, Fahey JL. Cytokine Gene Expression in Normal Human Lymphocytes in Response to Stimulation. Clinical & Diagnostic Laboratory Immuno, 1998; 5(3):335-340.

 

Breen EC, McDonald M, Fan J, Boscardin J, Fahey JL. Cytokine Gene Expression Occurs More Rapidly in Stimulated Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Persons. Clinical & Diagnostic Laboratory Immunology, 2000; 7(5): 769-773.

 

Wen SF, Xei L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL. Development and Validation of Sensitive Assays to Quantitate Gene Expression after p53 Gene Therapy and Paclitaxel Chemotherapy Using in vivo Dosing in Tumor Xenograft Models. Cancer Gene Therapy, 2000; 7(11): 1469-1480.

 

McDonald M.  2008. Primary Immunodeficiencies. In Buttaro TM, Trybulski J, Polgar-Bailey P, Sandburg-Cook J, editors.  Primary Care: A Collaborative Practice, 3^rd Ed. Philadelphia. Mosby.

 

 

Abstracts & Presentations

-Wills K, McDonald M, Neugebauer S, Philopena J, Vaillancourt M, Anderson S, Wen SF, Avanzini J, Faha B. Analysis of the Effect of Adenoviral Background on the Level and Persistence of Transgene Expression. Keystone Meeting on Gene Therapy-12/97.

 

-Beltran JC, McDonald M, Nodelman M, Simkovsky R, Wen SF, Obenauer-Kutner L, Hutchins B, Sugarman BJ. Methods for Characterizing Transgene Expression from Recombinant Adenoviral Vectors Encoding Cytokine Genes. Canji/Schering-Plough Retreat/Scientific Advisory Board Meeting-9/98.

 

-McDonald M, Monroy A, Fritz M, Bordens R, Wen SF, Hutchins B. Evaluation of Quantitative 5' Nuclease RT-PCR Assays for p53, p21^WAF1/CIP1, Bax, and Bcl-2 mRNA. Canji/Schering-Plough Retreat/Scientific Advisory Board Meeting-9/98.

 

-Wen SF, Hirai M, McDonald M, Maneval DC, Hutchins B, Talmadge JE. Efficiency of p53-Induced Apoptosis During Stem Cell Product Purging with Adenovirus p53. American Society of Hematology (Apoptosis) Meeting-12/98.

 

-Getting Through the Match.  As a panellist, answered questions about the National Residency Matching Program at the American College of Physicians Annual Session in San Diego, CA-4/03.

 

-Primary Immunodeficiencies. Resident research day, Dartmouth-Hitchcock Medical Center, NH-6/06.